About Biocon Our Business Research & Development Biocon's Technology Investors Media Careers CSR
Clinigene Profile
  Press Releases
  Media Stories
  Download Center
    Biocon Profile
    Ms. Kiran's Profile
    CSR Policy
    Annual Reports
    Financial Results
  Video Gallery
  Photo Gallery
  Media Contacts
  Download Center  
  Clinigene Profile  
  Click to download Clinigene Profile  

Clinigene International

Clinigene: India’s most experienced Biologics CRO
Clinigene is a full-service CRO for end-to-end clinical development of biopharmaceutical drugs, with extensive experience on novel biologics and biosimilars.
Our Services

  • Early phase studies: Dose Escalation, TQT, DDI and PK studies in special populations
  • Laboratory services: Central Lab, Biomarker analysis, immunoassay and cell-based assays
  • Late phase clinical development – extensive experience in Oncology, Diabetology and Immunology

Our facilities (early phase clinic, bio analytical lab and central lab) have been inspected by several regulatory agencies, incl. US-FDA and EMA. Our immunoassay lab is GLP and GCLP compliant.
Therapeutic Experience (partial list)

  • Solid Tumors
  • Non-Small Cell Lung Cancer (NSCLC)
  • Glioma
  • Head and Neck Cancer
  • Non-Hodgkins Lymphoma (NHL)
  • Metastatic Breast Cancer
  • Treatment-related complications


  • Type 1 & 2 Diabetes mellitus
  • Complications (Diabetic foot ulcer, Neuropathy, Nephropathy)


  • Osteoporosis
  • Chronic low back pain


  • Chronic Kidney Disease (CKD)
  • Anemia in CKD


  • Rheumatoid arthritis

Why Clinigene? Why India?

  • Clinigene has conducted over 200 clinical trials involving more than 11000 patients and healthy volunteers.
  • Clinigene has relationships with a large number of GCP certified investigators throughout India
    • Oncology – 96
    • Diabetes – 120
  • Clinigene’s investigator database includes internationally known KOLs
  • Extensive experience in working with American and European Sponsors
  • India has large treatment naïve patient populations in TAs such as oncology, Diabetology, metabolic disorders and CNS.
  • India has the best recruitment and retention rates amongst emerging markets
  • English Speaking investigators and staff
  • Cost Savings of 50% relative to US and Europe
Download Clinigene Profile
  Related links:
    Product Glossary
    Financial Highlights
    Photo Gallery


Recommended sites Biocon on  
About Us

Investor Relations
Media Relations
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Research Services
Active Discovery Program

Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
  Report adverse event/side effects and product complaints    
  * Disclaimer            © 2018, Biocon. All Rights Reserved